These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 748783

  • 21. Effects of urine and continued exposure to carcinogen on progression of early neoplastic urinary bladder lesions.
    Rowland RG, Henneberry MO, Oyasu R, Grayhack JT.
    Cancer Res; 1980 Dec; 40(12):4524-7. PubMed ID: 7438086
    [Abstract] [Full Text] [Related]

  • 22. Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Hosaka Y, Muramatsu M, Matsushima T, Niijima T, Nagase S.
    Jpn J Cancer Res; 1985 Jul; 76(7):577-82. PubMed ID: 3928553
    [Abstract] [Full Text] [Related]

  • 23. Immunologic features of a carcinogen-induced murine bladder cancer: in vivo and in vitro studies.
    Javadpour N, Hyatt CL, Soares T.
    J Surg Oncol; 1979 Jul; 11(2):153-9. PubMed ID: 86659
    [Abstract] [Full Text] [Related]

  • 24. The pathogenesis of bladder cancer.
    Friedell GH, Jacobs JB, Nagy GK, Cohen SM.
    Am J Pathol; 1977 Nov; 89(2):431-42. PubMed ID: 920778
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Experimental bladder tumor induction, propagation, and therapy.
    Williams PD, Murphy GP.
    Urology; 1976 Jul; 8(1):39-42. PubMed ID: 941358
    [Abstract] [Full Text] [Related]

  • 28. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.
    Sakata T, Hasegawa R, Johansson SL, Zenser TV, Cohen SM.
    Cancer Res; 1986 Aug; 46(8):3903-6. PubMed ID: 3731063
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Induction of transitional cell carcinoma of the urinary bladder in rats by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Histological and ultrastructural findings.
    Adolphs HD, Thiele J, Kiel H, Steffens L.
    Urol Res; 1978 Aug; 6(1):19-27. PubMed ID: 644727
    [Abstract] [Full Text] [Related]

  • 31. Development of an in vitro and in vivo epithelial tumor model for the study of invasion.
    Pauli BU, Anderson SN, Memoli VA, Kuettner KE.
    Cancer Res; 1980 Dec; 40(12):4571-80. PubMed ID: 7438091
    [Abstract] [Full Text] [Related]

  • 32. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
    Cohen SM, Zenser TV, Murasaki G, Fukushima S, Mattammal MB, Rapp NS, Davis BB.
    Cancer Res; 1981 Sep; 41(9 Pt 1):3355-9. PubMed ID: 6790163
    [Abstract] [Full Text] [Related]

  • 33. Comparative urinary and gallbladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide and N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide in the dog.
    Ertürk E, Atassi SA, Yoshida O, Cohen SM, Price JM, Bryan GT.
    J Natl Cancer Inst; 1970 Sep; 45(3):535-42. PubMed ID: 4331642
    [No Abstract] [Full Text] [Related]

  • 34. Adjuvant immunotherapy of N-[4(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder tumors.
    Ibraheim EH, El Kappany H, Nigam VN, Brailovsky CA, Madarnas P, Elhilali MM.
    Anticancer Res; 1984 Sep; 4(3):209-13. PubMed ID: 6465859
    [Abstract] [Full Text] [Related]

  • 35. Monoclonal antibodies to two mouse bladder carcinoma antigens.
    Hellström I, Rollins N, Settle S, Chapman P, Chapman WH, Hellström KE.
    Int J Cancer; 1982 Feb 15; 29(2):175-80. PubMed ID: 7037659
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of the effects of cotinine and nicotine-N'-oxides on the development of tumors in rats initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    LaVoie EJ, Shigematsu A, Rivenson A, Mu B, Hoffmann D.
    J Natl Cancer Inst; 1985 Dec 15; 75(6):1075-81. PubMed ID: 3865011
    [Abstract] [Full Text] [Related]

  • 37. Pathogenesis, histology, and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
    Ertürk E, Cohen SM, Price JM, Bryan GT.
    Cancer Res; 1969 Dec 15; 29(12):2219-28. PubMed ID: 5387262
    [No Abstract] [Full Text] [Related]

  • 38. N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder cancer in mice: augmentation by sutures through the bladder wall.
    Chester JF, Gaissert HA, Ross JS, Malt RA, Weitzman SA.
    J Urol; 1987 Apr 15; 137(4):769-71. PubMed ID: 3560345
    [Abstract] [Full Text] [Related]

  • 39. Enhancement by phenothiazine and 2,5-di-O-acetyl-D-glucosaccharo-(1,4)(6,3)-dilactone of bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in rats.
    Wang CY, Hayashida S.
    Cancer Lett; 1984 Aug 15; 24(1):37-43. PubMed ID: 6548659
    [Abstract] [Full Text] [Related]

  • 40. Malignant transformation of urinary bladder in humans and in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-exposed Fischer rats: ultrastructure of the major components of the permeability barrier.
    Merk FB, Pauli BU, Jacobs JB, Alroy J, Friedell GH, Weinstein RS.
    Cancer Res; 1977 Aug 15; 37(8 Pt 2):2843-53. PubMed ID: 872113
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.